Rodney Ellis, MD
Radiation Oncology · Tampa, FLNPI 1679508352
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (54.3%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 62.9% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2019 at $28,947 and has fallen 99.2% since, to $223 in 2025. Among radiation oncology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 60 payments — averaging $638.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$24K
- Angiodynamics, Inc.$6K
- Bayer$6K
- Viewray Technologies Inc$833
- Johnson & Johnson$251
- Elekta, Inc.$165
- plus $762 from 12 others
Across 3 payments — averaging $3008.97 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$9K
- Novartis$27
What the payments were for
- Consulting fees$20,81354%
- Speaking & faculty fees$11,97031%
- Travel & lodging$2,3856%
- Food & beverage$3,1558%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 27 | $24,097 |
| Angiodynamics, Inc. | 1 | $6,313 |
| Bayer | 4 | $5,902 |
| Viewray Technologies Inc | 8 | $833 |
| Johnson & Johnson | 2 | $251 |
| Elekta, Inc. | 1 | $165 |
| Theragenics Corporation | 1 | $163 |
| Neotract Inc. | 1 | $146 |
| Siemens Medical Solutions USA, Inc. | 3 | $95 |
| Brainlab, Inc. | 2 | $87 |
| Teleflex LLC | 1 | $63 |
| Novocure Inc. | 2 | $53 |
| Progenics Pharmaceuticals, Inc. | 2 | $44 |
| Telix Pharmaceuticals | 1 | $40 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| Myriad Genetic Laboratories, Inc. | 1 | $18 |
| Novo Nordisk | 1 | $18 |
| Sanofi | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL BPH$14,750
- SPACEOAR$6,905
- Xofigo$5,837
- GENERAL - THERAPIES$1,920
- MRIdian LINAC$551
- Erleada$251
- MRIdian$160
- UroLift$146
- GENERAL ONCOLOGY$111
How this compares
$38,322 in reported general payments places this provider in the 95th percentile of 465 radiation oncology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 18 | $171 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Tampa
- Jessica FrakesTampa$99K
- Alexander EngelmanTampa$80K
- John DavidTampa$49K
- Hsiang Hsuan YuTampa$24K
- Lorraine PortelanceTampa$14K
- Thomas DillingTampa$11K
- Kosj YamoahTampa$11K
- Sarah HoffeTampa$10K
- Shravan KandulaOrlando$444K
- Martin KeischMiami Shores$319K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.